Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway | 2018/02/01 | English | 168 |
Esters, amides and substituted derivatives of cinnamic acid: synthesis, antimicrobial activity and QSAR investigations | 2004/10/01 | English | 167 |
Alkyl esters of gallic acid as anticancer agents: A review | 2013/02/01 | English | 167 |
Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles | 2009/06/01 | English | 166 |
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease | 2016/01/01 | English | 166 |
Recent advances in natural products from plants for treatment of liver diseases | 2013/05/01 | English | 166 |
4-Quinolone hybrids and their antibacterial activities | 2017/12/01 | English | 166 |
1,5-Benzothiazepine, a versatile pharmacophore: A review | 2008/11/01 | English | 165 |
Synthesis and antimicrobial evaluation of some new thiazole, thiazolidinone and thiazoline derivatives starting from 1-chloro-3,4-dihydronaphthalene-2-carboxaldehyde | 2007/07/01 | English | 165 |
Synthesis and structure–activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells | 2008/11/01 | English | 163 |
An insight on medicinal attributes of 1,2,4-triazoles | 2020/11/01 | English | 163 |
Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles | 2010/10/01 | English | 162 |
Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives | 2018/05/01 | English | 162 |
Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents | 2015/09/01 | English | 161 |
Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities | 2009/02/01 | English | 161 |
Quinoline and quinolone dimers and their biological activities: An overview | 2019/01/01 | English | 161 |
Isoniazid derivatives and their anti-tubercular activity | 2017/06/01 | English | 161 |
Design and synthesis of anticonvulsants from a combined phthalimide–GABA–anilide and hydrazone pharmacophore | 2007/02/01 | English | 161 |
Synthesis and evaluation of new quinazolone derivatives of nalidixic acid as potential antibacterial and antifungal agents | 2006/02/01 | English | 161 |
The cytotoxic activity of ursolic acid derivatives | 2005/06/01 | English | 161 |
New quinoline derivatives: Synthesis and investigation of antibacterial and antituberculosis properties | 2010/08/01 | English | 160 |
CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones | 2008/09/01 | English | 160 |
2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents | 2013/01/01 | English | 159 |
Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site | 2018/05/01 | English | 159 |
Antimicrobial activity and a SAR study of some novel benzimidazole derivatives bearing hydrazone moiety | 2010/08/01 | English | 159 |
Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones | 2010/11/01 | English | 159 |
Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles | 2012/02/01 | English | 158 |
Recent advances of chroman-4-one derivatives: Synthetic approaches and bioactivities | 2015/03/01 | English | 157 |
Kaempferol, a potential cytostatic and cure for inflammatory disorders | 2014/10/01 | English | 157 |
Synthesis, biological evaluation and molecular docking of novel chalcone–coumarin hybrids as anticancer and antimalarial agents | 2014/10/01 | English | 157 |